Zobrazeno 1 - 10
of 167
pro vyhledávání: '"Duletić Načinović A"'
Autor:
Ita Hadžisejdić, Emina Babarović, Luka Vranić, Antica Duletić Načinović, Ksenija Lučin, Maja Krašević, Nives Jonjić
Publikováno v:
Diagnostic Pathology, Vol 12, Iss 1, Pp 1-7 (2017)
Abstract Background Plasmablastic lymphoma (PBL) is relatively new clinical entity described as a distinct subtype of diffuse large B-cell lymphoma (DLBCL). It is characterized by its aggressive nature and proliferation of large neoplastic cells rese
Externí odkaz:
https://doaj.org/article/b71f132528734b6aada58bfc0b6601b3
Autor:
Ita Hadžisejdić, Antica Duletić Načinović, Ivan Ševeljević, Luka Vranić, Nives Jonjić, Andrej Belančić
Publikováno v:
Pathology, research and practice
Volume 215
Issue 1
Volume 215
Issue 1
An association between autoimmune events, as well as the development of antiphospholipid (aPL) antibodies and lymphoproliferative disorders is well recognized. We present the patient with coagulation abnormalities and non- Hodgkin lymphoma (NHL), pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e62ee7897b4897a18defdb4ef438f1
https://doi.org/10.1016/j.prp.2018.10.020
https://doi.org/10.1016/j.prp.2018.10.020
Autor:
Pejša, Vlatko, Jakšić, Branimir, Ostojić Kolonić, Slobodanka, Bašić Kinda, Sandra, Coha, Božena, Gverić- Krečak, Velka, Jakšić, Ozren, Sinčić-Petričević, Jasminka, Gaćina, Petar, Kardum-Skelin, Ika, Bogeljić Patekar, Martina, Duletić-Načinović, Antica, Aurer, Igor
Nove smjernice za liječenje bolesnika s kroničnom limfocitnom leukemijom donesene su na temelju rezultata multicentričnih istraživanja za prvu liniju terapije te za liječenje relapsa/refraktorne bolesti. Nadamo se da će ove nove smjernice prido
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::bd1c61dc2d36c7ae18d1d063c0e324c8
https://www.bib.irb.hr/1177025
https://www.bib.irb.hr/1177025
Autor:
Toni Valković, Dora Fučkar Čupić, Nives Jonjić, Ksenija Lučin, Irena Seili Bekafigo, Antica Duletić Načinović
Publikováno v:
Applied immunohistochemistry & molecular morphology
Volume 24
Issue 10
Volume 24
Issue 10
Simultaneous occurrence of T-cell and B-cell neoplasms is rare, and etiologic relationships between these 2 malignancies are poorly understood. We describe the case of a 66-year-old woman who was admitted to the hospital because of fever, hemoptysis,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c149b2e3ec6ea89d13464dfa4b91453b
https://doi.org/10.1097/pai.0000000000000361
https://doi.org/10.1097/pai.0000000000000361
Autor:
Merica Aralica, Toni Valković, Antica Duletić-Načinović, Ksenija Lučin, Nives Jonjić, Irena Seili-Bekafigo, Emina Babarović, Sanja Štifter
Publikováno v:
BioMed Research International
Volume 2016
BioMed Research International, Vol 2016 (2016)
Volume 2016
BioMed Research International, Vol 2016 (2016)
The aim of this pilot study was to determine the plasma levels of monocyte chemotactic protein-1 (MCP-1) and possible associations with angiogenesis and the main clinical features of untreated patients with multiple myeloma (MM). ELISA was used to de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a88b3627dd22a3534987fe6ef6b45eb2
https://doi.org/10.1155/2016/7870590
https://doi.org/10.1155/2016/7870590
Autor:
Duletić-Načinović, Antica1
Publikováno v:
Rad Hrvatske Akademije Znanosti i Umjetnosti. Medicinske Znanosti. 2015, Vol. 524 Issue 42, p49-58. 10p.
Based on our earlier research into the main characteristics and risk factors for infections in hospitalized patients with multiple myeloma, we created the numerical Multiple Myeloma Index for Risk of Infection (MMIRI) to predict infection in myeloma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::9695af63ee53c0db84ed859ad1316335
https://www.bib.irb.hr/1104504
https://www.bib.irb.hr/1104504
Autor:
Maja Krašević, Antica Duletić Načinović, Emina Babarović, Nives Jonjić, Ksenija Lučin, Luka Vranić, Ita Hadžisejdić
Publikováno v:
Diagnostic Pathology
Volume 12
Issue 1
Diagnostic Pathology, Vol 12, Iss 1, Pp 1-7 (2017)
Volume 12
Issue 1
Diagnostic Pathology, Vol 12, Iss 1, Pp 1-7 (2017)
Background Plasmablastic lymphoma (PBL) is relatively new clinical entity described as a distinct subtype of diffuse large B-cell lymphoma (DLBCL). It is characterized by its aggressive nature and proliferation of large neoplastic cells resembling im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d10f7255e62e17ed69aec641dcf64ece
https://doi.org/10.1186/s13000-017-0672-x
https://doi.org/10.1186/s13000-017-0672-x
Publikováno v:
Medical Hypotheses. 81:1137-1140
Multiple myeloma is a common, yet incurable, haematological neoplasm. The reciprocal communication between malignant plasma cells, other cell types, and the extracellular matrix in the bone marrow micro-eco system is mediated by cell–cell and cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f067acd179d9d924d7f61751db857bdb
https://doi.org/10.1016/j.mehy.2013.10.021
https://doi.org/10.1016/j.mehy.2013.10.021
Publikováno v:
Diagnostic Cytopathology. 41:947-954
Multiple myeloma (MM) shows great variability in clinical course of the disease, and survival varies between a few months and more than 10 years. Myeloma plasma cells (PCs) can appear completely “normal” in morphology, but can also be overtly aty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::604f68bd1b0317581f9d771f8e31586c
https://doi.org/10.1002/dc.22986
https://doi.org/10.1002/dc.22986